Development
Lantern Pharma Inc.
LTRN
$3.32
-$0.11-3.21%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 44.93M | 47.95M | 51.54M | 55.20M | 57.83M |
| Total Receivables | -- | -- | -- | 592.00K | 305.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.70M | 1.86M | 1.53M | 760.00K | 1.04M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 797.00K | 1.23M | 2.10M | 2.17M | 2.85M |
| Total Current Assets | 47.43M | 51.04M | 55.17M | 58.72M | 62.02M |
|
|
|||||
| Total Current Assets | 47.43M | 51.04M | 55.17M | 58.72M | 62.02M |
| Net Property, Plant & Equipment | 319.70K | 358.20K | 308.80K | 95.70K | 126.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 25.90K | 25.90K | 33.00K | 17.90K | 17.90K |
| Total Assets | 47.77M | 51.43M | 55.51M | 58.84M | 62.16M |
|
|
|||||
| Total Accounts Payable | 1.57M | 1.70M | 1.19M | 932.40K | 986.00K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 168.00K | 163.10K | 119.60K | 52.90K | 92.00K |
| Total Finance Division Other Current Liabilities | 516.00K | 1.16M | 1.49M | 1.81M | 2.06M |
| Total Other Current Liabilities | 516.00K | 1.16M | 1.49M | 1.81M | 2.06M |
| Total Current Liabilities | 2.25M | 3.02M | 2.79M | 2.80M | 3.14M |
|
|
|||||
| Total Current Liabilities | 2.25M | 3.02M | 2.79M | 2.80M | 3.14M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 106.50K | 150.70K | 140.60K | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.36M | 3.17M | 2.93M | 2.80M | 3.14M |
|
|
|||||
| Common Stock & APIC | 96.61M | 96.42M | 96.03M | 95.69M | 95.36M |
| Retained Earnings | -51.06M | -47.90M | -43.15M | -39.28M | -35.90M |
| Treasury Stock & Other | -138.80K | -261.80K | -299.70K | -371.40K | -435.00K |
| Total Common Equity | 45.41M | 48.26M | 52.58M | 56.04M | 59.03M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 45.41M | 48.26M | 52.58M | 56.04M | 59.03M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 45.41M | 48.26M | 52.58M | 56.04M | 59.03M |
|
|
|||||